{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:32:10Z","timestamp":1780471930879,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.anndiagpath.2019.151414","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T01:59:50Z","timestamp":1571795990000},"page":"151414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enhanced cutaneous Rock2 expression as a marker of Rho Kinase pathway activation in autoimmune disease and Kohlemeier-Degos disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Cynthia","family":"Magro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Hedayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151414_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","article-title":"ROCK-I and ROCK-II, two isoforms of rho-associated coiled-coil forming protein serine\/threonine kinase in mice","volume":"392","author":"Nakagawa","year":"1996","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.151414_bb0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/ars.2013.5524","article-title":"Rho\/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis","volume":"20","author":"Sawada","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.151414_bb0015","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.3892\/mmr.2015.4409","article-title":"Fasudil, a rho-kinase inhibitor, prevents intima-media thickening in a partially ligated carotid artery mouse model: effects of fasudil in flow-induced vascular remodeling","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.151414_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10557-014-6544-7","article-title":"Vasodilatory effect of a novel rho-kinase inhibitor, DL0805-2, on the rat mesenteric artery and its potential mechanisms","volume":"28","author":"Yuan","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151414_bb0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","article-title":"Degos disease: a C5b-9\/interferon-\u03b1\u2013mediated endotheliopathy syndrome","volume":"135","author":"Magro","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151414_bb0030","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/annrheumdis-2016-209850","article-title":"Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE","volume":"76","author":"Rozo","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anndiagpath.2019.151414_bb0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2015.00276","article-title":"The function of rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease","volume":"6","author":"Hartmann","year":"2015","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151414_bb0040","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.37934","article-title":"Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus","volume":"65","author":"Isgro","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anndiagpath.2019.151414_bb0045","first-page":"359","article-title":"Y-27632, a rho-associated protein kinase inhibitor","volume":"88","author":"Wang","year":"2017","journal-title":"Inhibits Systemic Lupus Erythematosus Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151414_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1479164116687935","article-title":"Inhibition of rho kinase protects from ischaemia\u2013reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes","volume":"14","author":"Tratsiakovich","year":"2017","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151414_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2015.02.076","article-title":"Atorvastatin prevents angiotensin II-induced high permeability of human arterial endothelial cell monolayers via ROCK signaling pathway","volume":"459","author":"Yi","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151414_bb0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00296-015-3400-4","article-title":"Investigation of the association between rho\/rho-kinase gene polymorphisms and systemic sclerosis","volume":"36","author":"Pehlivan","year":"2016","journal-title":"Rheumatol Int"},{"issue":"45","key":"10.1016\/j.anndiagpath.2019.151414_bb0065","doi-asserted-by":"crossref","first-page":"34381","DOI":"10.1074\/jbc.M603680200","article-title":"Transactivation of Sphingosine 1-phosphate receptors is essential for vascular barrier regulation","volume":"281","author":"Singleton","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151414_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","article-title":"RhoA\/rho-kinase in the cardiovascular system","volume":"118","author":"Shimokawa","year":"2016","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.151414_bb0075","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/HYPERTENSIONAHA.116.07792","article-title":"Central angiotensin-II increases blood pressure and sympathetic outflow via rho kinase activation in conscious rabbits","volume":"68","author":"Pellegrino","year":"2016","journal-title":"Hypertension."},{"issue":"9","key":"10.1016\/j.anndiagpath.2019.151414_bb0080","article-title":"The role of the rho\/ROCK pathway in Ang II and TGF-\u03b21-induced atrial remodeling","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151414_bb0085","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bbrc.2011.07.031","article-title":"Thrombin induces MCP-1 expression through rho-kinase and subsequent p38MAPK\/NF-\u03baB signaling pathway activation in vascular endothelial cells","volume":"411","author":"Kawanami","year":"2011","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419303430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419303430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:30:42Z","timestamp":1761078642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913419303430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":17,"alternative-id":["S1092913419303430"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151414","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced cutaneous Rock2 expression as a marker of Rho Kinase pathway activation in autoimmune disease and Kohlemeier-Degos disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151414"}}